13.2% Stake of Genesis Healthcare, Inc. (NYSE:GEN) Owned by Onex Corp

Onex Corp

recently stated that they own a 13.2% stake in Genesis Healthcare, Inc. (NYSE:GEN) in a Form 13D/A disclosure that was filed with the Securities and Exchange Commission on Thursday, July 27th. The investor owns 11,757,791 shares of the stock valued at about $17,401,531. The reporting parties listed on the disclosure included Onex Corporation, Onex Partners LP, Onex US Principals LP, Onex Real Estate Holdings III Inc and Gerald W Schwartz. The disclosure is available through the SEC website at this link.

Onex Corp

provided the following explanation of their ownership:

Warning: file_get_contents(): php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/acctmp/public_html/download.php on line 6

Warning: file_get_contents(https://whalewisdom.com
11,757,791
): failed to open stream: php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/acctmp/public_html/download.php on line 6

Other hedge funds have also added to or reduced their stakes in the company. TIAA CREF Investment Management LLC raised its stake in Genesis Healthcare by 50.1% in the first quarter. TIAA CREF Investment Management LLC now owns 223,085 shares of the company’s stock worth $589,000 after buying an additional 74,502 shares during the last quarter. Alliancebernstein L.P. raised its stake in Genesis Healthcare by 2.6% in the first quarter. Alliancebernstein L.P. now owns 83,126 shares of the company’s stock worth $219,000 after buying an additional 2,100 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Genesis Healthcare by 500.3% in the first quarter. JPMorgan Chase & Co. now owns 1,026,169 shares of the company’s stock worth $2,709,000 after buying an additional 855,240 shares during the last quarter. Oxford Asset Management raised its stake in Genesis Healthcare by 298.0% in the first quarter. Oxford Asset Management now owns 159,106 shares of the company’s stock worth $420,000 after buying an additional 119,134 shares during the last quarter. Finally, TFS Capital LLC raised its stake in Genesis Healthcare by 477.5% in the first quarter. TFS Capital LLC now owns 156,019 shares of the company’s stock worth $412,000 after buying an additional 129,001 shares during the last quarter. Institutional investors own 14.40% of the company’s stock.

Genesis Healthcare, Inc. (NYSE GEN) traded down 2.03% during trading on Thursday, hitting $1.45. 174,723 shares of the stock were exchanged. The firm’s market capitalization is $134.46 million. Genesis Healthcare, Inc. has a 12-month low of $1.44 and a 12-month high of $4.75. The stock has a 50 day moving average price of $1.67 and a 200-day moving average price of $2.64.

Genesis Healthcare (NYSE:GEN) last announced its quarterly earnings results on Tuesday, May 9th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by $0.25. The firm had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.40 billion. Genesis Healthcare had a negative return on equity of 0.81% and a negative net margin of 1.27%. During the same period in the prior year, the business earned ($0.48) earnings per share. On average, equities research analysts anticipate that Genesis Healthcare, Inc. will post ($1.27) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “13.2% Stake of Genesis Healthcare, Inc. (NYSE:GEN) Owned by Onex Corp” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://stocknewstimes.com/2017/07/27/13-2-stake-of-genesis-healthcare-inc-nysegen-owned-by-onex-corp.html.

A number of analysts have recently issued reports on the company. Cantor Fitzgerald assumed coverage on Genesis Healthcare in a report on Wednesday, July 5th. They issued an “overweight” rating for the company. ValuEngine raised shares of Genesis Healthcare from a “strong sell” rating to a “sell” rating in a research note on Thursday, June 8th. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $2.65.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Institutional Ownership by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply